EUVIMEDEUVIMED entdecken
Crossref

Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil

Samuel Santos Pereira iD, Rafael Rahal Guaragna Machado, Jéssica Pires Farias, Robert Adreata-Santos iD, Mônica Josiane Rodrigues-Jesus, Mayanna Moreira Costa Fogaça, Milena Silva Souza, Eduardo Gimenes Martins, Camila Malta Romano, Edison Luiz Durigon, Jaime Henrique Amorim iD, Luís Carlos de Souza Ferreira

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Samuel Santos Pereira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Dengue Virus, Immunoglobulin G, Antibodies, Viral, Dengue. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), grant numbers 88887.600175/2021-00 and 8888130782/2016-00 (S.S.….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue is the most prevalent arboviral disease globally, with Brazil currently experiencing a significant rise in cases. Dengue virus (DENV) typically co‐circulates with other clinically and antigenically similar flaviviruses, such as Zika virus (ZIKV). The clinical diagnosis is difficult and accurate serological analysis represents an unmet challenge. Traditionally, serological analysis of DENV infection focuses on the acute phase via detection of NS1 or IgM. Developing IgG DENV‐specific assays has been defiant due to the co‐circulation of four antigenically distinct serotypes and a strong cross‐reactivity with other arboviruses, particularly with ZIKV. The goal of this study was to produce recombinant domain III of the Envelope (EDIII) proteins of each DENV serotype and ZIKV and evaluate the ability to detect specific IgG antibodies. The antigens were tested on the ELISA platform to measure DENV‐specific IgG in mice and patients infected with ZIKV and DENV. The assay differentiated serotype‐specific IgG responses in susceptible mice (AG129) experimentally infected with DENV or ZIKV. In addition, the test demonstrated a robust performance achieving 87.8% sensitivity and 91.4% specificity when tested against 648 well‐characterized sera collected from humans infected with DENV and/or ZIKV. The test was further applied to serum samples collected from 318 healthy individuals from an endemic region in Northwest/Central Brazil, without a previous diagnosis of DENV, and revealed that 65% of the samples reacted with at least one DENV serotype antigen, including 123 monotypic samples (88 for DENV‐1) and 90 samples reacting with multiple antigens. Collectively, these results indicate that the IgG DENV‐EDIII ELISA is a valuable tool for assessing the serological status of populations in endemic areas, particularly in regions where other flaviviruses, particularly ZIKV, co‐circulate and offer support to establish public health policies against the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusImmunoglobulin GAntibodies, ViralDengueSerogroupRecombinant ProteinsZika VirusZika Virus InfectionSensitivity and SpecificityHumansBrazilAnimalsMiceEnzyme-Linked Immunosorbent AssayAntigens, ViralEndemic DiseasesViral Envelope ProteinsCross ReactionsSerologic Tests

Stichwörter der Autor:innen

DENVEDIIIELISAZIKVserological tests

Substanzen

Immunoglobulin GAntibodies, ViralRecombinant ProteinsAntigens, ViralViral Envelope Proteins

Autor:innen und Institutionen

  • Laboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Laboratory of Clinical and Molecular Virology, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Western Bahia Virology Institute, Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Bahia, Brazil.
  • Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

ORCID-Profile: Samuel Santos Pereira, Robert Adreata-Santos, Jaime Henrique Amorim

Förderung

  • This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), grant numbers 88887.600175/2021-00 and 8888130782/2016-00 (S.S.…

Zitieren

APA

Pereira, S. S., Machado, R. R. G., Farias, J. P., Adreata-Santos, R., Rodrigues-Jesus, M. J., Fogaça, M. M. C., Souza, M. S., Martins, E. G., Romano, C. M., Durigon, E. L., Amorim, J. H., & Ferreira, L. C. S. (2024). Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil. Journal of Medical Virology. https://doi.org/10.1002/jmv.70100

Vancouver

Pereira SS, Machado RRG, Farias JP, Adreata-Santos R, Rodrigues-Jesus MJ, Fogaça MMC, et al. Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil. Journal of Medical Virology. 2024. doi:10.1002/jmv.70100

BibTeX
@article{Pereira2024,
  author = {Pereira, Samuel Santos and Machado, Rafael Rahal Guaragna and Farias, Jéssica Pires and Adreata-Santos, Robert and Rodrigues-Jesus, Mônica Josiane and Fogaça, Mayanna Moreira Costa and Souza, Milena Silva and Martins, Eduardo Gimenes and Romano, Camila Malta and Durigon, Edison Luiz and Amorim, Jaime Henrique and Ferreira, Luís Carlos de Souza},
  title = {Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70100}
}
Kostenlos starten →